ID   RN167_HUMAN             Reviewed;         350 AA.
AC   Q9H6Y7; D3DTK8; Q6XYE0; Q8NDC1; Q9Y3V1;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 136.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF167;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger protein 167;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF167 {ECO:0000305};
DE   AltName: Full=RING105;
DE   Flags: Precursor;
GN   Name=RNF167; ORFNames=LP2254;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SLC22A18, MUTAGENESIS
RP   OF ILE-232 AND TRP-260, UBIQUITINATION, AND TISSUE SPECIFICITY.
RX   PubMed=16314844; DOI=10.1038/sj.onc.1209167;
RA   Yamada H.Y., Gorbsky G.J.;
RT   "Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel
RT   ubiquitin ligase RING105.";
RL   Oncogene 25:1330-1339(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May act as an E3 ubiquitin-protein ligase, or as part of
CC       the E3 complex, which accepts ubiquitin from specific E2
CC       ubiquitin-conjugating enzymes, such as UBE2E1, and then transfers
CC       it to substrates, such as SLC22A18. May play a role in growth
CC       regulation involved in G1/S transition.
CC       {ECO:0000269|PubMed:16314844}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with SLC22A18. {ECO:0000269|PubMed:16314844}.
CC   -!- SUBCELLULAR LOCATION: Endomembrane system
CC       {ECO:0000269|PubMed:16314844}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:16314844}. Note=Targeted to cytoplasmic
CC       membranes.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in the kidney and liver (at
CC       protein level). {ECO:0000269|PubMed:16314844}.
CC   -!- PTM: Auto-ubiquitinated in vitro in the presence of UBE2D1 and
CC       UBE2E1. {ECO:0000269|PubMed:16314844}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP34453.1; Type=Frameshift; Positions=65; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL050060; CAB43253.1; -; mRNA.
DR   EMBL; AL834284; CAD38958.1; -; mRNA.
DR   EMBL; AK025329; BAB15113.1; -; mRNA.
DR   EMBL; AY203930; AAP34453.1; ALT_FRAME; mRNA.
DR   EMBL; CR457340; CAG33621.1; -; mRNA.
DR   EMBL; CH471108; EAW90385.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90387.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90388.1; -; Genomic_DNA.
DR   EMBL; BC010139; AAH10139.1; -; mRNA.
DR   CCDS; CCDS11060.1; -.
DR   PIR; T08729; T08729.
DR   RefSeq; NP_001307285.1; NM_001320356.1.
DR   RefSeq; NP_001307286.1; NM_001320357.1.
DR   RefSeq; NP_001307287.1; NM_001320358.1.
DR   RefSeq; NP_001307288.1; NM_001320359.1.
DR   RefSeq; NP_001307289.1; NM_001320360.1.
DR   RefSeq; NP_001307290.1; NM_001320361.1.
DR   RefSeq; NP_001307291.1; NM_001320362.1.
DR   RefSeq; NP_001307292.1; NM_001320363.1.
DR   RefSeq; NP_001307293.1; NM_001320364.1.
DR   RefSeq; NP_001307294.1; NM_001320365.1.
DR   RefSeq; NP_056343.1; NM_015528.2.
DR   RefSeq; XP_016879916.1; XM_017024427.1.
DR   UniGene; Hs.7158; -.
DR   ProteinModelPortal; Q9H6Y7; -.
DR   SMR; Q9H6Y7; -.
DR   BioGrid; 117477; 21.
DR   IntAct; Q9H6Y7; 18.
DR   STRING; 9606.ENSP00000262482; -.
DR   iPTMnet; Q9H6Y7; -.
DR   PhosphoSitePlus; Q9H6Y7; -.
DR   SwissPalm; Q9H6Y7; -.
DR   BioMuta; RNF167; -.
DR   DMDM; 74733620; -.
DR   EPD; Q9H6Y7; -.
DR   MaxQB; Q9H6Y7; -.
DR   PaxDb; Q9H6Y7; -.
DR   PeptideAtlas; Q9H6Y7; -.
DR   PRIDE; Q9H6Y7; -.
DR   Ensembl; ENST00000262482; ENSP00000262482; ENSG00000108523.
DR   Ensembl; ENST00000571816; ENSP00000459324; ENSG00000108523.
DR   Ensembl; ENST00000572430; ENSP00000458794; ENSG00000108523.
DR   Ensembl; ENST00000575111; ENSP00000460190; ENSG00000108523.
DR   GeneID; 26001; -.
DR   KEGG; hsa:26001; -.
DR   UCSC; uc002fzs.4; human.
DR   CTD; 26001; -.
DR   DisGeNET; 26001; -.
DR   GeneCards; RNF167; -.
DR   HGNC; HGNC:24544; RNF167.
DR   HPA; HPA049810; -.
DR   MIM; 610431; gene.
DR   neXtProt; NX_Q9H6Y7; -.
DR   OpenTargets; ENSG00000108523; -.
DR   PharmGKB; PA134953711; -.
DR   eggNOG; KOG4628; Eukaryota.
DR   eggNOG; ENOG410Z5DF; LUCA.
DR   GeneTree; ENSGT00760000119057; -.
DR   HOGENOM; HOG000234362; -.
DR   HOVERGEN; HBG063762; -.
DR   InParanoid; Q9H6Y7; -.
DR   KO; K15706; -.
DR   OMA; CIARRET; -.
DR   OrthoDB; EOG091G08WC; -.
DR   PhylomeDB; Q9H6Y7; -.
DR   TreeFam; TF317486; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF167; human.
DR   GenomeRNAi; 26001; -.
DR   PRO; PR:Q9H6Y7; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108523; -.
DR   CleanEx; HS_RNF167; -.
DR   ExpressionAtlas; Q9H6Y7; baseline and differential.
DR   Genevisible; Q9H6Y7; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR011016; Znf_RING-CH.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00744; RINGv; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Membrane; Metal-binding;
KW   Polymorphism; Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    350       E3 ubiquitin-protein ligase RNF167.
FT                                /FTId=PRO_0000245593.
FT   TRANSMEM    174    194       Helical. {ECO:0000255}.
FT   DOMAIN       49    152       PA.
FT   ZN_FING     230    272       RING-type; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     121    121       N -> K (in dbSNP:rs1127356).
FT                                /FTId=VAR_026996.
FT   MUTAGEN     232    232       I->A: Drastically increased stability;
FT                                reduction in auto-ubiquitination
FT                                activity; loss of cell delay/arrest in
FT                                G1. {ECO:0000269|PubMed:16314844}.
FT   MUTAGEN     260    260       W->A: Drastically increased stability;
FT                                reduction in auto-ubiquitination
FT                                activity; loss of cell delay/arrest in
FT                                G1. {ECO:0000269|PubMed:16314844}.
FT   CONFLICT    224    224       Missing (in Ref. 1; CAD38958).
FT                                {ECO:0000305}.
SQ   SEQUENCE   350 AA;  38299 MW;  D87493CE24C2A418 CRC64;
     MHPAAFPLPV VVAAVLWGAA PTRGLIRATS DHNASMDFAD LPALFGATLS QEGLQGFLVE
     AHPDNACSPI APPPPAPVNG SVFIALLRRF DCNFDLKVLN AQKAGYGAAV VHNVNSNELL
     NMVWNSEEIQ QQIWIPSVFI GERSSEYLRA LFVYEKGARV LLVPDNTFPL GYYLIPFTGI
     VGLLVLAMGA VMIARCIQHR KRLQRNRLTK EQLKQIPTHD YQKGDQYDVC AICLDEYEDG
     DKLRVLPCAH AYHSRCVDPW LTQTRKTCPI CKQPVHRGPG DEDQEEETQG QEEGDEGEPR
     DHPASERTPL LGSSPTLPTS FGSLAPAPLV FPGPSTDPPL SPPSSPVILV
//
